BDBM62533 3-[(2-chlorophenyl)methyl]-N-(2,3-dihydro-1,4-benzodioxin-6-yl)-5-methyl-7-triazolo[4,5-d]pyrimidinamine::3-[(2-chlorophenyl)methyl]-N-(2,3-dihydro-1,4-benzodioxin-6-yl)-5-methyl-[1,2,3]triazolo[4,5-d]pyrimidin-7-amine::3-[(2-chlorophenyl)methyl]-N-(2,3-dihydro-1,4-benzodioxin-6-yl)-5-methyltriazolo[4,5-d]pyrimidin-7-amine::MLS000034177::SMR000007991::[3-(2-Chloro-benzyl)-5-methyl-3H-[1,2,3]triazolo[4,5-d]pyrimidin-7-yl]-(2,3-dihydro-benzo[1,4]dioxin-6-yl)-amine::[3-(2-chlorobenzyl)-5-methyl-triazolo[4,5-d]pyrimidin-7-yl]-(2,3-dihydro-1,4-benzodioxin-6-yl)amine::cid_646338

SMILES C[C@H]1CCCN(C(=O)c2cnc3c(c2)OCCN3c2ccn3c(=O)[nH]nc3c2)C1

InChI Key InChIKey=YMAWBSBIRBUXSK-UHFFFAOYSA-N

Data  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 62533   

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Kyorin Pharmaceutical Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 62533BDBM62533(US12577217, Example 1-42)
Affinity DataIC50: 10nMAssay Description:Compounds were added to a 384-well plate. Reaction mixtures contained 10 mM HEPES, pH 7.4, 10 mM MgCl2, 0.01% BSA, 0.0005% Tween 20, 1 mM ATP and 1 &...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/27/2026
Entry Details
US Patent